Additionally, our results indicate that ERβ can function as a molecular switch for EZH2 and repurpose it for anti-cancer effects, findings that may help clarify the paradox between EZH2, H3K27me3, and TNBC patient outcomes. This evidence concerns the gene ESR2 and cancer.